|
Volumn 158, Issue 10, 2013, Pages 776-
|
Cost-effectiveness of generic antiretroviral therapy
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
EMTRICITABINE;
GENERIC DRUG;
LAMIVUDINE;
TENOFOVIR;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
ANTIRETROVIRAL THERAPY;
ANTIVIRAL THERAPY;
COST CONTROL;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
DRUG EFFICACY;
DRUG SAFETY;
HUMAN;
LETTER;
PRIORITY JOURNAL;
SYSTEMATIC REVIEW (TOPIC);
THERAPY EFFECT;
ECONOMICS;
FEMALE;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
MALE;
NOTE;
ANTI-HIV AGENTS;
DRUGS, GENERIC;
FEMALE;
HIV INFECTIONS;
HUMANS;
MALE;
|
EID: 84878066368
PISSN: 00034819
EISSN: 15393704
Source Type: Journal
DOI: 10.7326/0003-4819-158-10-201305210-00015 Document Type: Letter |
Times cited : (7)
|
References (6)
|